SCHEMBL1639435

SCHEMBL1639435

[c]1nc(-c2conn2)cs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL718110 0.68 CYP1A2 (0.34)
SCHEMBL17444516 0.68
SCHEMBL113248 0.67 LMNA (0.41)
SCHEMBL4931947 0.67 KMT2A (0.39)
SCHEMBL8482556 0.67
SCHEMBL1667738 0.64
SCHEMBL9316319 0.63 PTK2 (0.42)
SCHEMBL28450892 0.63 KMO (0.34)
SCHEMBL549435 0.63 MAPT (0.50)
SCHEMBL8482558 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185812-A1 INHIBITORS OF cGAS FOR TREATING AUTOINFLAMMATORY DISEASES AND CANCER METASTASIS THE ROCKEFELLER UNIVERSITY (US) 2022-06-16 US disclosed
EP-3937932-A1 INHIBITORS OF CGAS FOR TREATING AUTOINFLAMMATORY DISEASES AND CANCER METASTASIS Tomita, Daisuke (US) 2022-01-19 EP disclosed
WO-2020186027-A1 INHIBITORS OF CGAS FOR TREATING AUTOINFLAMMATORY DISEASES AND CANCER METASTASIS TOMITA DAISUKE (US) 2020-09-17 WO disclosed
US-20180250293-A1 AZAINDAZOLE COMPOUNDS AND METHODS OF USE CHEMOCENTRYX INC (US) 2018-09-06 US disclosed
US-20160296517-A1 AZAINDAZOLE COMPOUNDS AND METHODS OF USE CHEMOCENTRYX, INC. 2016-10-13 US disclosed
US-9296740-B2 Azaindazole compounds and methods of use CHEMOCENTRYX, INC. (US) 2016-03-29 US disclosed
US-9045583-B2 Polyurethane resin adhesion pigment, pigment dispersion composition and inkjet ink composition TOKAI CARBON CO., LTD. (JP) 2015-06-02 US disclosed
US-20140357636-A1 Treatment of Skeletal-Related Disorders ROTHBAUM WAYNE (US) 2014-12-04 US disclosed
US-20130338157-A1 AZAINDAZOLE COMPOUNDS AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2013-12-19 US disclosed
US-20130165584-A1 POLYURETHANE RESIN ADHESION PIGMENT, PIGMENT DISPERSION COMPOSITION AND INKJET INK COMPOSITION TOKAI CARBON CO., LTD. (JP) 2013-06-27 US disclosed
US-8383630-B2 Azaindazole compounds and methods of use CHEMOCENTRYX, INC. (US) 2013-02-26 US disclosed
US-20110098308-A1 AZAINDAZOLE COMPOUNDS AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2011-04-28 US disclosed
US-7777035-B2 Azaindazole compounds and methods of use CHEMOCENTRYX, INC. (US) 2010-08-17 US disclosed
US-20090252779-A1 AZAINDAZOLE COMPOUNDS AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2009-10-08 US disclosed
US-7524845-B2 Azaindazole compounds and methods of use CHEMOCENTRYX, INC. (US) 2009-04-28 US disclosed
US-20080058341-A1 AZAINDAZOLE COMPOUNDS AND METHODS OF USE CHEMOCENTRYX, INC. 2008-03-06 US disclosed
US-20070010524-A1 Azaindazole compounds and methods of use CHEMOCENTRYX, INC. (US) 2007-01-11 US disclosed